inositol has been researched along with conduritol epoxide in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (34.02) | 18.7374 |
1990's | 19 (19.59) | 18.2507 |
2000's | 17 (17.53) | 29.6817 |
2010's | 25 (25.77) | 24.3611 |
2020's | 3 (3.09) | 2.80 |
Authors | Studies |
---|---|
Hara, A; Radin, NS | 1 |
Bernatsky, A; Kanfer, JN; Legler, G; Stephens, MC | 1 |
Bernatsky, A; Burachinsky, V; Kanfer, JN; Legler, G; Stephens, MC | 1 |
Falchetto, R; Keller, P; Legler, G; Semenza, G; Wacker, H | 1 |
Aerts, JM; Barranger, JA; Hong, CM; Ohashi, T; Tager, JM; Tomich, JM; Weiler, S | 1 |
Abe, A; Deshmukh, GD; Mahdiyoun, S; Radin, NS; Shayman, JA | 1 |
Hermans, MM; Kroos, MA; Oostra, BA; Reuser, AJ; van Beeumen, J | 1 |
Maley, F; Reddy, VA | 1 |
Butcher, BA; Glew, RH; Gopalan, V; Lee, RE; Richards, TC; Waggoner, AS | 1 |
Aerts, JM; Barranger, JA; Donker-Koopman, WE; Koot, M; Schram, AW; Tager, JM | 1 |
Bourbouze, R; Donsimoni, R; Lalegerie, P; Legler, G | 1 |
McCluer, RH; Newburg, DS; Raghavan, S; Yatziv, S | 1 |
Desnick, RJ; Dinur, T; Fabbro, D; Gatt, S; Grabowski, GA; Legler, G; Osiecki-Newman, K | 1 |
Datta, SC; Radin, NS | 1 |
Basu, A; Das, S; Glew, RH; Lamarco, KL; Legler, G; Martinez, AJ; Nerad, TA; Saha, AK | 1 |
Umezurike, GM | 1 |
Aerts, JM; Barranger, JA; Magalhaes, JA; Pinto, RA; Sa Miranda, MC; Schram, AW; Tager, JM | 1 |
Barfi, G; Kolodny, EH; Livni, N; Newburg, DS; Yatziv, S | 1 |
McCluer, RH; Newburg, DS; Raghavan, SS; Shea, TB; Yatziv, S | 1 |
Desnick, RJ; Dinur, T; Gatt, S; Grabowski, GA; Legler, G; Osiecki, KM | 1 |
Alhadeff, JA; Legler, G; Schray, KJ; White, WJ | 1 |
Barranger, JA; Das, PK; Gal, AE; Murray, GJ | 1 |
Ge, SG; Yang, SJ; Zeng, YC; Zhang, SZ | 1 |
Basu, A; Glew, RH | 2 |
Barranger, JA; Das, PK; Murray, GJ | 1 |
Dinur, T; Gatt, S; Grabowski, GA; Kruse, JR; Legler, G; Osiecki, KM | 1 |
Boyd, SA; Lee, KJ; Radin, NS | 1 |
Fiehn, NE; Moe, D | 1 |
Herrchen, M; Legler, G | 2 |
Radin, NS; Vunnam, RR | 1 |
Daniels, LB; Glew, RH; Radin, NS; Vunnam, RR | 1 |
Bernatsky, A; Kanfer, JN; Legler, G; Singh, H; Stephens, MC | 1 |
Daniels, LB; Diven, WF; Glew, RH; Lee, RE; Radin, NS | 1 |
Desnick, RJ; Dinur, T; Gatt, S | 1 |
Kanfer, JN; Legler, G; Singh, H; Stephens, MC | 1 |
Blair, H; Bull, GM; Gregoriadis, G; Weereratne, H | 1 |
Futerman, AH; Hirschberg, K; Rapaport, E; Schwarz, A | 1 |
Chiba, S; Honma, M; Ito, H; Iwanami, S; Kimura, A; Matsui, H; Mori, H | 1 |
Elias, PM; Holleran, WM; Marsh, NL | 1 |
Goto, I; Kobayashi, T; Sasagasako, N; Yamaguchi, Y | 1 |
Gatt, S; Grabowski, G; Hirschberg, JG; Kohen, C; Kohen, E; Mangel, W; Prince, J; Santus, R | 1 |
Aerts, JM; Brandsma, M; Strijland, A; Tager, JM; van Weely, S | 1 |
Chaturvedi, P; Newburg, DS; Prence, EM | 1 |
Elias, PM; Feingold, KR; Hanley, K; Holleran, WM; Jiang, Y; Williams, ML | 1 |
Barone, R; D'Auria, S; De Napoli, L; Febbraio, F; Nucci, R; Orrù, S; Piccialli, G; Pucci, P; Rossi, M | 1 |
Chiba, S; Fukushi, Y; Kimura, A; Matsui, H; Mori, H; Takata, M | 1 |
Brown, BE; Elias, PM; Holleran, WM; Marchell, NL; Uchida, Y | 1 |
Eghtesad, B; Glew, RH; Hays, WS; Johnston, DE; Wheeler, DE | 1 |
Day, AJ; DuPont, MS; Morgan, MR; Rhodes, M; Rhodes, MJ; Ridley, S; Williamson, G | 1 |
Futerman, AH; Korkotian, E; Pelled, D; Schwarz, A; Schwarzmann, G; Segal, M | 1 |
Futerman, AH; Pelled, D; Shogomori, H | 1 |
Falshaw, A; Hart, JB; Tyler, PC | 1 |
Chen, FY; Chir, J; Li, YK | 1 |
Aouali, N; Belhoussine, R; Levade, T; Manfait, M; Morjani, H; Veldman, RJ | 1 |
De Gori, R; Driguez, H; Fincher, GB; Hrmova, M; Smith, BJ; Varghese, JN | 1 |
Bodennec, J; Futerman, AH; Pelled, D; Riebeling, C; Trajkovic, S | 1 |
Chiba, S; Fukuda, K; Kimura, A; Mori, H; Okuyama, M; Ozaki, H; Yoneyama, M | 1 |
Andrews, L; Chan, KW; Copeland, D; Fung, J; Karey, K; Simons, B; Waire, J | 1 |
Brady, RO; Kaneski, CR; Kolter, T; Sandhoff, K; Schueler, UH; Zirzow, GC | 1 |
Casas, J; Delgado, A; Egido-Gabás, M; Llebaria, A; Serrano, P | 1 |
Boldin-Adamsky, S; Futerman, AH; Kelly, JW; Premkumar, L; Sawkar, AR; Silman, I; Sussman, JL; Toker, L | 1 |
Delgado, A; Llebaria, A; Serrano, P | 1 |
Hayashi, Y; Ito, M; Kakuta, Y; Narimatsu, H; Okino, N; Shikanai, T; Tani, M | 1 |
Grabowski, GA; Huelsken, J; Quinn, B; Reboulet, R; Witte, D; Xu, YH | 1 |
Anelli, V; Grabowski, GA; Hannun, YA; Jenkins, RW; Kitatani, K; Obeid, LM; Sheldon, K; Sun, Y | 1 |
Langston, JW; Manning-Boğ, AB; Schüle, B | 1 |
Boivin, MN; Campeau, PM; Galipeau, J; Grabowski, GA; Rafei, M; Sun, Y | 1 |
Arosa, FA; Balreira, A; Cavallari, M; Sá Miranda, MC | 1 |
Berger, J; Berger, MG; Boiret-Dupré, N; Boisgard, S; Caillaud, C; Chomienne, C; Larghero, J; Lecourt, S; Marolleau, JP; Rapatel, C; Vanneaux, V | 1 |
Grabowski, GA; Quinn, B; Ran, H; Sun, Y; Witte, D; Xu, YH | 1 |
Goldin, E; Gruschus, JM; Lee, JC; Moaven, N; Sidransky, E; Velayati, A; Westbroek, W; Yap, TL | 1 |
Belmatoug, N; Caillaud, C; Chomienne, C; Cras, A; Freida, D; Heraoui, D; Herbi, L; Larghero, J; Lecourt, S; Marolleau, JP; Vanneaux, V | 1 |
Imokawa, G; Sawada, E; Yoshida, N | 1 |
Chau, KY; Cleeter, MW; Duchen, M; Gluck, C; Hardy, J; Hughes, DA; Mark Cooper, J; Mehta, A; Schapira, AH; Wood, NW | 1 |
Dermentzaki, G; Dimitriou, E; Michelakakis, H; Stefanis, L; Xilouri, M | 1 |
Platt, FM; Rahim, AA; Ridley, CM; Shanahan, J; Shen, A; Thillaiappan, NB; Thur, KE; Uhl, K; van der Spoel, AC; Waddington, SN; Walden, CM | 1 |
Ceci, R; de Francesco, PN; Delpino, MV; Di Genaro, S; Fossati, CA; Mucci, JM; Rozenfeld, PA; Suqueli García, F | 1 |
Akbarian, S; Chou, VP; Ginns, EI; Guo, Y; Karlgren, J; Ko, N; LaMarca, ML; Lim, A; Mak, SK; Manning-Boğ, AB; Samuelsson, S; Vazquez-DeRose, J | 1 |
Grabowski, GA; Li, RH; Liou, B; Quinn, B; Setchell, KD; Sun, Y; Witte, D; Xu, K; Xu, YH; Xue, L; Zhang, W | 1 |
Beagan, J; Brown, E; Cao, H; Graham, AR; Hallett, PJ; Hayes, MA; Isacson, O; Izen, SC; McLean, JR; Park, E; Perez-Torres, E; Rocha, EM; Smith, GA | 1 |
Alvarez-Fischer, D; Andreas, H; Hirsch, EC; Höglinger, GU; Höllerhage, M; Lu, L; Noelker, C; Oertel, WH; Roscher, R; Sturn, A; Vulinovic, F | 1 |
Allaire, A; Bangari, DS; Budman, E; Cheng, SH; Cromwell, MA; Grabowski, GA; Leonard, JP; Marshall, J; Nietupski, JB; Park, H; Sun, Y; Wang, B | 1 |
Brayer, GD; Caner, S; Chen, HM; Jiang, J; Nguyen, NT; Overkleeft, H; Withers, SG; Zhang, X | 1 |
Hayashi, Y; Ito, M | 1 |
Eilam, R; Futerman, AH; Kenwood, BM; Klein, AD; Massaro, G; Merrill, AH; Meshcheriakova, A; Rahim, AA; Vardi, A; Vitner, EB; Yaacobi, C; Zigdon, H | 1 |
Ben-Dor, S; Cox, TM; Duan, J; Ferreira, NS; Futerman, AH; Hardy, J; Klein, AD; Merrill, AH | 1 |
Bondar, C; Crivaro, A; Delpino, MV; Ferreyra-Compagnucci, M; Mucci, JM; Ormazabal, M; Rozenfeld, PA | 1 |
Burke, DG; de la Fuente, C; Eaton, S; Heales, SJR | 1 |
Antoniadou, I; Arianoglou, G; Emmanouilidou, E; Karachaliou, A; Nikolopoulou, G; Papadopoulos, VE; Sardi, SP; Stefanis, L; Vekrellis, K | 1 |
Blandini, F; Cerri, S; Ghezzi, C; Giuliano, C; Mus, L; Siani, F | 1 |
Aerts, JMFG; Artola, M; Futerman, AH; Kallemeijn, WW; Kuo, CL; Lelieveld, LT; Meijer, AH; Mirzaian, M; Overkleeft, HS; Spaink, HP; Vardi, A; Zoutendijk, I | 1 |
Chan, MY; Svenningsson, P; Zurbruegg, M | 1 |
Castro, H; Macedo, MF; Ribeiro, H; Rocha, MI | 1 |
Aivazidis, S; Burbidge, KJ; Fredriksen, K; Gelyana, E; Mazzulli, JR; Pitcairn, C; Sharma, K; Zunke, F | 1 |
Alcantud, JL; Arrebola, F; Duran, R; Hardy, J; Lewis, PA; Manzoni, C; Ruz, C; Vives, F | 1 |
1 review(s) available for inositol and conduritol epoxide
Article | Year |
---|---|
Klotho-Related Protein KLrP: Structure and Functions.
Topics: Animals; Brain; Crystallography, X-Ray; Cytosol; Fibroblasts; Gaucher Disease; Gene Knockdown Techniques; Glucosylceramidase; Glucosylceramides; Glucuronidase; Humans; Hydrogen-Ion Concentration; Inositol; Klotho Proteins; Models, Molecular; Molecular Structure; Mutation; Rats; Zebrafish | 2016 |
96 other study(ies) available for inositol and conduritol epoxide
Article | Year |
---|---|
Destruction and resynthesis of mouse beta-glucosidases.
Topics: Animals; beta-Glucosidase; Brain; Glucosidases; Glucosylceramidase; Hematocrit; Hydrogen-Ion Concentration; Inositol; Kidney; Liver; Organ Size; Phenylhydrazines; Spleen | 1979 |
Studies on the possible identity of particulate beta-glucosidase and beta-xylosidase of mouse liver.
Topics: Animals; beta-Glucosidase; Gluconates; Glucosidases; Glycoside Hydrolases; Hydrogen-Ion Concentration; Inositol; Kinetics; Lactones; Liver; Mice; Taurocholic Acid; Xylosidases | 1979 |
The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
Topics: Acetylglucosaminidase; Animals; beta-Glucosidase; Brain; Cerebrosides; Gaucher Disease; Humans; Inositol; Liver; Male; Mice; Spleen | 1978 |
Location of the two catalytic sites in intestinal lactase-phlorizin hydrolase. Comparison with sucrase-isomaltase and with other glycosidases, the membrane anchor of lactase-phlorizin hydrolase.
Topics: 1-Deoxynojirimycin; Amino Acid Sequence; Animals; beta-Galactosidase; Binding Sites; Catalysis; DNA; Glucosamine; Glycoside Hydrolases; Inositol; Intestines; Lactase; Lactase-Phlorizin Hydrolase; Microvilli; Molecular Sequence Data; Oligo-1,6-Glucosidase; Rabbits; Sequence Homology, Nucleic Acid; Sucrase | 1992 |
Characterization of human glucocerebrosidase from different mutant alleles.
Topics: Alleles; Blotting, Northern; Blotting, Western; Chromatography, Affinity; DNA; Glucosylceramidase; Glycoproteins; Hot Temperature; Humans; Inositol; Mutagenesis, Site-Directed; Mutation; Phosphatidylserines; RNA; Saposins; Transfection | 1991 |
Decreased formation of inositol trisphosphate in Madin-Darby canine kidney cells under conditions of beta-glucosidase inhibition.
Topics: Animals; beta-Glucosidase; Bradykinin; Cell Line; Dogs; Galactose; Glucosylceramides; Guanosine 5'-O-(3-Thiotriphosphate); Inositol; Inositol 1,4,5-Trisphosphate; Kidney; Kinetics; Palmitic Acid; Palmitic Acids; Radioisotope Dilution Technique; Sphingolipids; Tritium | 1992 |
Human lysosomal alpha-glucosidase. Characterization of the catalytic site.
Topics: alpha-Glucosidases; Amino Acid Sequence; Base Sequence; Binding Sites; Chromatography, High Pressure Liquid; DNA Mutational Analysis; Glycoside Hydrolase Inhibitors; Humans; Inositol; Lysosomes; Molecular Sequence Data; Oligonucleotides; Peptide Fragments; Protein Processing, Post-Translational; Structure-Activity Relationship | 1991 |
Identification of an active-site residue in yeast invertase by affinity labeling and site-directed mutagenesis.
Topics: Acetylglucosaminidase; Affinity Labels; Amino Acid Sequence; Aspartic Acid; Base Sequence; beta-Fructofuranosidase; Binding Sites; Catalysis; Chromatography, High Pressure Liquid; Glycoside Hydrolases; Glycosylation; Inositol; Kinetics; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Molecular Sequence Data; Mutation; Peptide Fragments; Saccharomyces cerevisiae; Trypsin | 1990 |
Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
Topics: beta-Glucosidase; Brain; Gaucher Disease; Genetic Carrier Screening; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Hydrolysis; Immunoenzyme Techniques; Inositol; Leukocytes; Liver; Placenta; Taurocholic Acid; Umbelliferones | 1989 |
Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.
Topics: Adolescent; Adult; beta-N-Acetylhexosaminidases; Child; Female; Gaucher Disease; Glucosidases; Glucosides; Glucosylceramidase; Hexosaminidases; Humans; Hymecromone; Inositol; Male; Middle Aged; Substrate Specificity | 1986 |
Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
Topics: 1-Deoxynojirimycin; Animals; beta-Glucosidase; Glucosamine; Glucosidases; Helix, Snails; Hydrogen-Ion Concentration; Inositol; Kinetics; Substrate Specificity | 1988 |
beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
Topics: Animals; beta-Glucosidase; Cells, Cultured; Dose-Response Relationship, Drug; Gaucher Disease; Glucosidases; Glucosylceramides; Inositol; Macrophages; Mice; Models, Biological; Peritoneum; Time Factors | 1986 |
Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
Topics: beta-Glucosidase; Gaucher Disease; Glucosidases; Humans; Immunoglobulin G; Inositol; Kinetics; Mathematics; Placenta | 1986 |
Glucosylceramide and the level of the glucosidase-stimulating proteins.
Topics: Animals; beta-Glucosidase; Body Weight; Brain; Cell Membrane; Cerebrosides; Cytosol; Glucosidases; Glucosylceramides; Glycoproteins; Inositol; Kinetics; Liver; Mice; Mice, Inbred Strains; Organ Size; Proteins; Saposins | 1986 |
Partial purification and characterization of Naegleria fowleri beta-glucosidase.
Topics: Amoeba; Animals; beta-Glucosidase; Chromatography, Gel; Disaccharides; Glucosidases; Hot Temperature; Hydrogen-Ion Concentration; Inositol; Isoelectric Focusing; Kinetics; Microscopy, Electron; Substrate Specificity | 1987 |
The mechanism of action of beta-glucosidase from Botryodiplodia theobromae Pat.
Topics: beta-Glucosidase; Dioxanes; Glucosidases; Glycerol; Inositol; Kinetics; Mitosporic Fungi; Sodium Chloride | 1987 |
Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
Topics: beta-Glucosidase; Electrophoresis; Electrophoresis, Cellulose Acetate; Female; Fibroblasts; Gaucher Disease; Glucosidases; Glucosylceramidase; Glycoproteins; Humans; Inositol; Isoelectric Point; Kidney; Leukocytes; Liver; Phosphatidylserines; Placenta; Pregnancy; Saposins; Solvents; Sphingolipid Activator Proteins; Spleen; Taurocholic Acid | 1988 |
Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
Topics: Blood Cells; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Inositol; Macrophages; Microscopy, Electron | 1988 |
Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
Topics: Animals; Gaucher Disease; Glucosidases; Glucosylceramidase; Glucosylceramides; Inositol; Lysosomes; Macrophages; Mice; Mice, Inbred C57BL | 1988 |
Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.
Topics: Amino Acid Sequence; Base Sequence; Binding Sites; DNA; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Inositol; Lysosomes; Peptides; Sequence Homology, Nucleic Acid | 1986 |
Active-site-directed inactivation of human liver alpha-L-fucosidase by conduritol C trans-epoxide.
Topics: alpha-L-Fucosidase; Binding Sites; Humans; Hydrogen-Ion Concentration; Inositol; Kinetics; Liver; Stereoisomerism | 1986 |
Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cerebrosides; Glucosidases; Glucosylceramidase; Glucosylceramides; Inositol; Kinetics; Liposomes; Lysosomes; Macrophages; Rats | 1987 |
Inactivation of alpha-glucosidase by the active-site-directed inhibitor, conduritol B epoxide.
Topics: Binding Sites; Glucosidases; Glycoside Hydrolase Inhibitors; Hydrogen-Ion Concentration; Inositol; Kinetics; Maltose | 1985 |
Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
Topics: Animals; beta-Glucosidase; Chemical Phenomena; Chemistry, Physical; Dose-Response Relationship, Drug; Enzyme Activation; G(M1) Ganglioside; Gangliosides; Gaucher Disease; Glucosidases; Glucosides; Hot Temperature; Humans; Hymecromone; Inositol; Kinetics; Liver; Lysosomes; Male; Micelles; Molecular Weight; Rats; Rats, Inbred Strains; Temperature | 1985 |
Studies on the turnover of glucocerebrosidase in cultured rat peritoneal macrophages and normal human fibroblasts.
Topics: Animals; Cells, Cultured; Chemical Precipitation; Fibroblasts; Glucosidases; Glucosylceramidase; Humans; Immunochemistry; Inositol; Kinetics; Macrophages; Peritoneal Cavity; Rats | 1986 |
Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Topics: Adolescent; Adult; Binding Sites; Cells, Cultured; Child; Child, Preschool; Female; Fibroblasts; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Inositol; Jews; Male; Middle Aged; Mutation; Phenotype; Sphingosine | 1985 |
Improved synthesis of conduritol B epoxide.
Topics: Chemical Phenomena; Chemistry; Chromatography, Gas; Chromatography, Thin Layer; Indicators and Reagents; Inositol | 1985 |
Effect of seven inhibitors on invertases in homogenates of human dental plaque.
Topics: 1-Deoxynojirimycin; Acarbose; beta-Fructofuranosidase; Dental Plaque; Glucosamine; Glucosidases; Glycoside Hydrolase Inhibitors; Glycoside Hydrolases; Humans; Inositol; Peptides; Piperidones; Trisaccharides | 1983 |
Active site-directed inhibition of galactosidases by conduritol C epoxides (1,2-anhydro-epi- and neo-inositol).
Topics: alpha-Galactosidase; Animals; beta-Galactosidase; beta-Glucosidase; Cattle; Escherichia coli; Galactosidases; Helix, Snails; Inositol; Kinetics; Plants; Spleen; Structure-Activity Relationship | 1981 |
Identification of an essential carboxylate group at the active site of lacZ beta-galactosidase from Escherichia coli.
Topics: beta-Galactosidase; Binding Sites; Borohydrides; Carboxylic Acids; Catalysis; Chemical Phenomena; Chemistry; Escherichia coli; Galactosidases; Inositol | 1984 |
Inhibitors of cerebroside metabolism.
Topics: Animals; Cerebrosides; Galactosylceramidase; Glucosylceramidase; Glucosyltransferases; Indicators and Reagents; Inositol; Morpholines; Propiophenones; Propylene Glycols; Sphingosine | 1981 |
Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
Topics: Animals; Enzyme Activation; Glucosidases; Glucosylceramidase; Hydrogen-Ion Concentration; Inositol; Kinetics; Liver; Male; Phosphatidylserines; Phospholipids; Proteins; Rats; Rats, Inbred Strains | 1984 |
A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Topics: beta-Glucosidase; Clinical Enzyme Tests; Fluorometry; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Inositol; Liver | 1980 |
Distribution of conduritol B epoxide in the animal model for Gaucher's disease (Gaucher mouse).
Topics: Animals; beta-Glucosidase; Blood-Brain Barrier; Disease Models, Animal; Gaucher Disease; Glucosidases; Humans; Inositol; Mice; Tissue Distribution | 1981 |
An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
Topics: Adolescent; beta-Glucosidase; Clinical Enzyme Tests; Female; Fibroblasts; Fluorometry; Gaucher Disease; Genetic Carrier Screening; Glucosidases; Glucosylceramidase; Homozygote; Humans; Inositol; Leukocytes; Male; Taurocholic Acid | 1981 |
Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
Topics: beta-Glucosidase; Detergents; Europe; Gaucher Disease; Glucosidases; Glucosides; Humans; Hydrolysis; Inositol; Jews; Psychosine | 1982 |
The Gaucher mouse.
Topics: Acid Phosphatase; Animals; beta-Glucosidase; Brain; Cerebrosides; Disease Models, Animal; Galactosylceramides; Gangliosides; Gaucher Disease; Humans; Inositol; Mice; Myelin Sheath; Spleen | 1982 |
Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model.
Topics: Adult; Animals; beta-Glucosidase; Disease Models, Animal; Female; Gaucher Disease; Glucosidases; Glucosylceramidase; Humans; Inositol; Liposomes; Mice; Mice, Inbred BALB C | 1982 |
A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching.
Topics: Animals; Axons; Cells, Cultured; Dendrites; Fumonisins; Hippocampus; In Vitro Techniques; Inositol; Morpholines; Mycotoxins; Neurons; Rats; Rats, Wistar; Sphingolipids | 1995 |
Chemical modification and amino acid sequence of active site in sugar beet alpha-glucosidase.
Topics: alpha-Glucosidases; Amino Acid Sequence; beta-Glucosidase; Chromatography, High Pressure Liquid; Electrophoresis; Glycoside Hydrolase Inhibitors; Inositol; Kinetics; Molecular Sequence Data; Plants; Protein Conformation; Ultracentrifugation | 1995 |
Glucosylceramides stimulate murine epidermal hyperproliferation.
Topics: Animals; Cell Division; Epidermal Cells; Glucosylceramidase; Glucosylceramides; Inflammation; Inositol; Male; Mice; Sphingolipids | 1995 |
The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
Topics: Acylation; beta-Glucosidase; Cells, Cultured; Cerebrosides; Fibroblasts; Glucosylceramides; Glucosyltransferases; Glycosylation; Humans; Inositol; Morpholines; Psychosine; Sphingosine | 1994 |
An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
Topics: beta-Galactosidase; beta-Glucosidase; Cells, Cultured; Fibroblasts; Fluorescent Dyes; Gaucher Disease; Glycosides; Homozygote; Humans; Inositol; Lysosomes; Microscopy, Fluorescence; Molecular Probes; Spectrometry, Fluorescence | 1993 |
Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
Topics: beta-Glucosidase; Cells, Cultured; Gaucher Disease; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Isoenzymes; Lysosomes | 1993 |
In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
Topics: alpha-Mannosidase; beta-Galactosidase; beta-Glucosidase; Cell Line; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Glycolipids; Humans; Inositol; Kinetics; Lysosomes; Mannosidases; Microscopy, Electron; Models, Biological; Neuroblastoma; Tumor Cells, Cultured | 1996 |
Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat.
Topics: Animals; Dexamethasone; Diethylstilbestrol; Embryonic and Fetal Development; Enzyme Inhibitors; Epidermis; Gestational Age; Glucosylceramidase; Glucosylceramides; Glucosyltransferases; Hormones; Inositol; Microscopy, Electron; Organ Culture Techniques; Permeability; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triiodothyronine | 1997 |
Identification of the active site nucleophile in the thermostable beta-glycosidase from the archaeon Sulfolobus solfataricus expressed in Escherichia coli.
Topics: Amino Acid Sequence; beta-Glucosidase; Binding Sites; Cloning, Molecular; Enzyme Inhibitors; Escherichia coli; Glucosidases; Glycoside Hydrolases; Inositol; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; Protein Conformation; Recombinant Proteins; Sequence Homology, Amino Acid; Sulfolobus | 1997 |
A catalytic amino acid and primary structure of active site in Aspergillus niger alpha-glucosidase.
Topics: alpha-Glucosidases; Amino Acid Sequence; Aspartic Acid; Aspergillus niger; Binding Sites; Enzyme Inhibitors; Inositol; Kinetics; Molecular Sequence Data; Sequence Analysis; Sequence Homology, Amino Acid; Structure-Activity Relationship | 1997 |
Glucosylceramides stimulate mitogenesis in aged murine epidermis.
Topics: Administration, Topical; Aging; Animals; Animals, Newborn; DNA; Enzyme Inhibitors; Epidermal Cells; Epidermis; Glucosylceramidase; Glucosylceramides; Hyperplasia; Inositol; Male; Mice; Mice, Hairless; Mitogens | 1998 |
Expression of cytosolic beta-glucosidase in guinea pig liver cells.
Topics: Animals; beta-Glucosidase; Carbon Tetrachloride; Cells, Cultured; Cytosol; Enzyme Inhibitors; Extracellular Space; Female; Glucosides; Guinea Pigs; Hydrolysis; Inositol; Liver; Male | 1998 |
Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity.
Topics: beta-Glucosidase; Cell Extracts; Cell-Free System; Chamomile; Cytosol; Flavanones; Flavonoids; Genistein; Gluconates; Glycosides; Glycosylation; Humans; Inositol; Intestine, Small; Isoflavones; Lactones; Liver; Oils, Volatile; Plants, Medicinal; Quercetin; Rutin; Taurocholic Acid | 1998 |
Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.
Topics: Animals; Calcium; Cells, Cultured; Embryo, Mammalian; Endoplasmic Reticulum; Gangliosides; Glucosylceramidase; Glucosylceramides; Hippocampus; Inositol; Kinetics; Lysosomes; Neurons; Rats; Rats, Wistar; Time Factors | 1999 |
The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.
Topics: Animals; Antimetabolites; Carboxylic Acids; Cell Death; Cells, Cultured; Enzyme Inhibitors; Fumonisins; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Hippocampus; Inositol; Neurons; Neurotoxins; Rats; Rats, Wistar; Recombinant Proteins | 2000 |
New syntheses of 1D- and 1L-1,2-anhydro-myo-inositol and assessment of their glycosidase inhibitory activities.
Topics: Aspergillus oryzae; Bacterial Proteins; beta-Galactosidase; beta-Glucosidase; Carbohydrate Conformation; Enzyme Inhibitors; Fungal Proteins; Geobacillus stearothermophilus; Glycoside Hydrolase Inhibitors; Glycoside Hydrolases; Indolizines; Inositol; Magnetic Resonance Spectroscopy; Plant Proteins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2000 |
Catalytic mechanism of a family 3 beta-glucosidase and mutagenesis study on residue Asp-247.
Topics: Aspartic Acid; beta-Glucosidase; Catalysis; Enzyme Inhibitors; Flavobacterium; Inositol; Kinetics; Magnetic Resonance Spectroscopy; Mutagenesis, Site-Directed; Substrate Specificity | 2001 |
Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets.
Topics: Cell Nucleus; Cytoplasm; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glucosylceramides; Humans; Inositol; Microscopy, Confocal; Neoplasms; Tumor Cells, Cultured | 2001 |
Catalytic mechanisms and reaction intermediates along the hydrolytic pathway of a plant beta-D-glucan glucohydrolase.
Topics: Catalytic Domain; Crystallography, X-Ray; Cyclohexanols; Fluorodeoxyglucose F18; Glucose; Glucosidases; Hordeum; Hydrolysis; Inositol; Models, Chemical; Models, Molecular; Peptide Mapping; Quantum Theory | 2001 |
Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
Topics: Animals; Axons; Brain; Carbon Radioisotopes; Cell Division; Choline; Choline-Phosphate Cytidylyltransferase; Enzyme Activation; Enzyme Inhibitors; Galactosylceramides; Gaucher Disease; Genotype; Glucosylceramidase; Glucosylceramides; Inositol; Lipid Metabolism; Mice; Mutation; Neurons; Phosphatidylcholines; Rats | 2002 |
Identification of essential ionizable groups and evaluation of subsite affinities in the active site of beta-D-glucosidase F1 from a Streptomyces sp.
Topics: Algorithms; Amino Acid Sequence; beta-Glucosidase; Binding Sites; Catalysis; Hydrogen-Ion Concentration; Inositol; Kinetics; Molecular Sequence Data; Oligosaccharides; Streptomyces; Substrate Specificity; Temperature | 2002 |
Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flow Cytometry; Glucosylceramidase; Inositol; Liver; Lysosomes; Mice; Mice, Inbred BALB C; Reproducibility of Results | 2004 |
Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
Topics: Animals; Cell Culture Techniques; Cell Line; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocyte Membrane; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Heterozygote; Inositol; Lipid Metabolism; Macrophages; Mice; Microscopy, Electron | 2004 |
New aminocyclitols as modulators of glucosylceramide metabolism.
Topics: Enzyme Inhibitors; Glucosidases; Glucosylceramides; Hexosamines; Inositol; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Optical Rotation; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2005 |
X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.
Topics: beta-Glucosidase; Binding Sites; Catalysis; Crystallography, X-Ray; Gaucher Disease; Humans; Inositol; Models, Molecular | 2005 |
Regio- and stereoselective synthesis of aminoinositols and 1,2-diaminoinositols from conduritol B epoxide.
Topics: Amines; Epoxy Compounds; Indicators and Reagents; Inositol; Magnetic Resonance Spectroscopy; Models, Molecular; Stereoisomerism | 2005 |
Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; Crystallography, X-Ray; Cytosol; Drug Resistance; Fibroblasts; Gene Expression; Glucose; Glucosylceramidase; Glucosylceramides; Glucuronidase; Humans; Inositol; Klotho Proteins; Lysosomes; Mice; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Recombinant Proteins; RNA, Small Interfering; Zebrafish; Zebrafish Proteins | 2007 |
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels.
Topics: Animals; Central Nervous System; Cytokines; Disease Models, Animal; Disease Progression; Female; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Glycosphingolipids; Inositol; Keratinocytes; Male; Mice; Mice, Transgenic; Phenotype | 2008 |
Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid.
Topics: Blotting, Western; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Ceramides; Enzyme-Linked Immunosorbent Assay; Female; Gene Silencing; Glucosylceramidase; Humans; Inositol; Interleukin-6; Mitogen-Activated Protein Kinase 13; Phosphorylation; Protein Kinase C; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2009 |
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Cell Differentiation; Disease Models, Animal; Dose-Response Relationship, Drug; Gaucher Disease; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Inositol; Mice; Mice, Inbred C57BL; Neuroblastoma; RNA, Messenger; Substantia Nigra | 2009 |
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.
Topics: Adipocytes; Amino Acid Substitution; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Chemokine CCL2; Cholesterol; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Female; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Humans; Inflammation Mediators; Inositol; Interleukin-8; Lysosomes; Male; Middle Aged; Mutation, Missense; Osteocytes; Stromal Cells; Up-Regulation | 2009 |
Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness.
Topics: Antigens, CD1d; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cell Line; Chronic Disease; Coculture Techniques; Enzyme Inhibitors; Gaucher Disease; Globosides; Hexosaminidases; Histocompatibility Antigens Class II; Humans; Inflammation; Inositol; Monocytes; Natural Killer T-Cells; Protein Multimerization; RNA, Messenger; Tretinoin; Trihexosylceramides; Up-Regulation | 2010 |
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease.
Topics: Bone Marrow Cells; Cell Proliferation; Cells, Cultured; Colony-Forming Units Assay; Enzyme Inhibitors; Flow Cytometry; Gaucher Disease; Glucosylceramidase; Hematopoiesis; Hematopoietic Stem Cells; Humans; Inositol; Models, Biological; Tissue Culture Techniques | 2010 |
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.
Topics: Age Factors; alpha-Synuclein; Animals; beta-Glucosidase; Brain; Disease Models, Animal; Gaucher Disease; Glucosylceramides; Inclusion Bodies; Inositol; Mice; Mutation, Missense; Phenotype; Psychosine; Ubiquitin | 2011 |
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.
Topics: alpha-Synuclein; Amino Acid Substitution; Cell Line, Tumor; Enzyme Inhibitors; Gaucher Disease; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Lysosomes; Multiprotein Complexes; Mutation, Missense; Parkinson Disease | 2011 |
Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency.
Topics: Bone Marrow; Bone Resorption; Cell Cycle; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cellular Microenvironment; Culture Media, Conditioned; Gaucher Disease; Glucosylceramidase; Humans; Inositol; Mesenchymal Stem Cells; Models, Biological; Osteoblasts; Osteoclasts | 2012 |
A reconstructed human epidermal keratinization culture model to characterize ceramide metabolism in the stratum corneum.
Topics: Acid Ceramidase; Cell Culture Techniques; Cells, Cultured; Ceramides; Desipramine; Epidermis; Feasibility Studies; Gene Expression Regulation; Glucosylceramidase; Glucosyltransferases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inositol; Interleukin-1alpha; Keratinocytes; Models, Biological; Morpholines; Sphingolipids; Sphingomyelin Phosphodiesterase; Tretinoin | 2012 |
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blotting, Western; Cell Line; Electron Transport; Enzyme Inhibitors; Free Radicals; Glucosylceramidase; Humans; Indicators and Reagents; Inositol; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Phosphorylation; Proteasome Endopeptidase Complex; Ubiquitin | 2013 |
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
Topics: alpha-Synuclein; Animals; Autophagy; Cell Differentiation; Cell Line; Gaucher Disease; Glucosylceramidase; Humans; Inositol; Lysosomes; Neurons; Parkinson Disease; Protein Multimerization; Rats | 2013 |
β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
Topics: 1-Deoxynojirimycin; Animals; beta-Glucosidase; Cell Line, Tumor; Cerebellar Ataxia; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Inositol; Mice; Spastic Paraplegia, Hereditary | 2013 |
Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Topics: Animals; Antigens, Differentiation; Bone Marrow Cells; Calcification, Physiologic; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Gaucher Disease; Inositol; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoblasts; Osteoclasts; Osteolysis; Tumor Necrosis Factor-alpha | 2013 |
Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Evoked Potentials, Motor; Female; Gaucher Disease; Glucosylceramidase; Humans; Inflammation; Inositol; Male; Mice; MicroRNAs; Mutation; Neuronal Plasticity; Parkinson Disease; Synapses; Synaptic Transmission | 2014 |
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
Topics: alpha-Synuclein; Amyloid beta-Protein Precursor; Animals; beta-Glucosidase; Cells, Cultured; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Enzyme Inhibitors; Gaucher Disease; Gene Expression Regulation; Hippocampus; Humans; Inositol; Lysosomal Membrane Proteins; Membrane Transport Proteins; Mice; Microtubule-Associated Proteins; Mitochondria; Mitochondrial Proteins; Neurons; Prostaglandin-Endoperoxide Synthases; Protein Aggregation, Pathological; Substantia Nigra | 2014 |
Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice.
Topics: alpha-Synuclein; Animals; Autophagy; Axonal Transport; Cerebral Cortex; Complement Activation; Complement C1q; Glucosylceramidase; Inositol; Male; Mice; Microglia; Parkinson Disease, Secondary; Protein Aggregation, Pathological; Proteins; Synaptic Transmission | 2015 |
Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
Topics: 1-Deoxynojirimycin; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cell Count; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Gaucher Disease; Glycoside Hydrolase Inhibitors; Histocompatibility Antigens; Inositol; L-Lactate Dehydrogenase; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Neurons; Parkinsonian Disorders; Tyrosine 3-Monooxygenase | 2015 |
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.
Topics: Administration, Oral; Animals; Carbamates; Central Nervous System; Disease Models, Animal; Enzyme Inhibitors; Gaucher Disease; Glucosyltransferases; Glycolipids; Humans; Inositol; Liver; Lysosomes; Mice; Quinuclidines; Tissue Distribution; Treatment Outcome | 2016 |
Glucosyl epi-cyclophellitol allows mechanism-based inactivation and structural analysis of human pancreatic α-amylase.
Topics: Catalytic Domain; Computer Simulation; Cyclohexanols; Disaccharides; Epoxy Compounds; Humans; Hydrogen Bonding; Inositol; Kinetics; Mass Spectrometry; Models, Molecular; Pancreatic alpha-Amylases; Water; X-Ray Diffraction | 2016 |
Delineating pathological pathways in a chemically induced mouse model of Gaucher disease.
Topics: Animals; Disease Models, Animal; Gaucher Disease; Gene Expression Profiling; Inositol; Mice | 2016 |
Identification of Modifier Genes in a Mouse Model of Gaucher Disease.
Topics: Animals; Base Sequence; Disease Models, Animal; Gaucher Disease; Genes, Modifier; Genome-Wide Association Study; Injections; Inositol; Longevity; Mice, Inbred Strains; Phenotype; Polymorphism, Single Nucleotide; Receptors, N-Methyl-D-Aspartate | 2016 |
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Differentiation; Cell Line; Connexin 43; Culture Media, Conditioned; Female; Gaucher Disease; Inositol; Integrin beta Chains; Interleukin-6; Macrophages; Mice, Inbred C57BL; Models, Biological; Osteoclasts; Osteocytes; Osteogenesis; Osteoprotegerin; RANK Ligand; Solubility | 2017 |
Inhibition of neuronal mitochondrial complex I or lysosomal glucocerebrosidase is associated with increased dopamine and serotonin turnover.
Topics: Cell Line, Tumor; Dopamine; Electron Transport Complex I; Enzyme Inhibitors; Glucosylceramidase; Humans; Inositol; Lysosomes; Mitochondria; Neurons; Serotonin | 2017 |
Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Exosomes; Glucosylceramidase; Humans; Inositol; Lysosomes; Mice; Mutation; Parkinson Disease | 2018 |
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Glucosylceramidase; Inositol; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders | 2019 |
In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Topics: Animals; beta-Glucosidase; Brain; Cyclohexanols; Disease Models, Animal; Enzyme Assays; Glucosylceramidase; Glycoside Hydrolase Inhibitors; HEK293 Cells; Humans; Inositol; Isoenzymes; Kinetics; Larva; Lysosomes; Mice; Parkinson Disease; Zebrafish | 2019 |
GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-β-epoxide increases levels of total α-synuclein in SH-SY5Y cells.
Topics: alpha-Synuclein; Animals; Cell Line, Tumor; Cerebral Cortex; Glucosylceramidase; Humans; Inositol; Neurons; Rats; Rats, Wistar; RNA Interference | 2019 |
Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages.
Topics: Animals; Enzyme Inhibitors; Flow Cytometry; Gaucher Disease; Glucosylceramidase; Inositol; Leishmania; Leishmania infantum; Leishmania major; Leishmania mexicana; Lysosomes; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Phagocytosis | 2020 |
Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo.
Topics: alpha-Synuclein; Amino Acid Sequence; Animals; Brain; Cathepsins; Cell Differentiation; Glycosphingolipids; Humans; Induced Pluripotent Stem Cells; Inositol; Lysosomes; Mice; Time Factors | 2021 |
Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line.
Topics: Cell Line; Cell Line, Tumor; Enzyme Inhibitors; Glioma; Glucosylceramidase; Humans; Inositol; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lysosomes; Mutation; Parkinson Disease | 2022 |